Text Size: a  |   a 

Psoriasis Risk Elevated in MS Patients

April 28, 2017

Researchers from Israel have found that multiple sclerosis (MS) patients have a high rate of comorbid psoriasis compared with patients without MS. This may be related to interferon beta exposure during treatment for MS, according to data published in the Journal of the Neurological Sciences.

The case-control study included 214 consecutive patients with MS and 192 consecutive patients without MS but with headaches. Nine of 214 MS patients were diagnosed with plague psoriasis, compared with only one of the 192 patients with headaches. Results also showed that six psoriasis cases among 143 female MS patients and three psoriasis among 71 male patients. Six of those nine patients started interferon-beta treatment after being diagnosed with MS, and four of the patients experienced exacerbation of psoriasis during exposure to interferon-beta. The researchers noted that the six patients with both MS and psoriasis had onset of psoriasis before that of MS.

The study supports previous data that there is an associate between MS with autoimmune diseases and supports the hypothesis of autoimmune pathogenesis for MS. The findings for this study should raise the level of awareness of psoriasis among MS patients.

Via Clinical Advisor